Abstract
The aim of the study was to identify lymph node micrometastases in order to demonstrate the prognosis of colorectal cancer patients staged I and II undergoing curative surgery. We conducted a prospective study on a total of 44 patients with stage I–III colorectal cancer, undergoing radical surgery at the Fifth Department of Surgery of Cluj-Napoca Municipal Clinical Hospital between September 2012 and January 2015. For the identification of micrometastases we used the sentinel lymph node mapping by two techniques, in vivo and ex vivo. In N0 patients we conducted an immunohistochemical study to identify micrometastases. Patients were followed 3 years after surgery to identify possible relapses. The mean age was 63 years, 24 patients were males and 20 (45.5%) women. Ten patients (12.8%) had stage I cancer, 12 patients (27.3%) had stage II cancer, and 22 had stage III cancer. Sentinel lymph node detection rate was similar for the in vivo technique and for the ex vivo technique. The percentage for the detection of micrometastases was 25% in vivo and 33.3% ex vivo. The 3-year postoperative recurrence rate was 25% in overstaged patients. The presence of micrometastases should be considered as a negative prognostic factor in patients with stage I and II colorectal cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stephen, B.E., Byrd, D.R., Compton, C.C., et al.: Part III Digestive system: colon and rectum. In: Anonymous AJCC Cancer Staging Manual, 2017, 8th edn. Springer, New York (2017)
Figueredo, A., Coombes, M.E., Mukherjee, S.: Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst. Rev. 3 (2008)
Micu, B., Micu, C., Gherman, A., Sava, M., Pop, T.R., Constantea, N.: The role of sentinel lymph node analysis in patients with colorectal cancer undergoing surgery. HVM Bioflux 7(2), 114–117 (2015)
Sloothaak, D.A., Sahami, S., van der Zaag-Loonen, H.J., van der Zaag, E.S., Tanis, P.J., Bemelman, W.A., et al.: The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis. Eur. J. Surg. Oncol. 40(3), 263–269 (2014)
Märkl, B., Herbst, C., Cacchi, C., et al.: Prognostic significance of histologically detected lymph node micrometastases of sizes between 0.2 and 2 mm in colorectal cancer. Int. J. Colorectal Dis. 28(7), 977–983 (2013)
van der Zaag, E.S., Bouma, W.H., Tanis, P.J., et al.: Systematic review of sentinel lymph node mapping procedure in colorectal cancer. Ann. Surg. Oncol. 19(11), 3449–3459 (2012)
Saha, S., Wiese, D., Badin, J., et al.: Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann. Surg. Oncol. 7(2), 120–124 (2000)
Wong, J.H., Steineman, S., Calderia, C., et al.: Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann. Surg. 233(5), 155–221 (2001)
Iddings, D., Ahmad, A., Elashoff, D., Bilchik, A.: The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann. Surg. Oncol. 13, 1386 (2006)
Viehl, C.T., Guller, U., Langer, I., et al.: Factors influencing the success of in vivo sentinel lymph node procedure in colon cancer patients: Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer 37(4), 873–877 (2013)
Wang, F.L., Shen, F., Wan, D.S., Lu, Z.H., Li, L.R., Chen, G., et al.: Ex vivo localization and immunohistochemical detection of sentinel lymph node micrometastasis in patients with colorectal cancer can upgrade tumor staging. Diagn Pathol. 22(7), 71 (2012)
Sloothaak, D.A.M., van der Linden, R.L.A., van de Velde, C.J.H., Bemelman, W.A., Lips, D.J., van der Linden, J.C., et al.: Prognostic implications of occult nodal tumour cells in stage I and II colon cancer: the correlation between micrometastasis and disease recurrence. Eur. J. Surg. Oncol. 43(8), 1456–1462 (2017)
Estrada, O., Pulido, L., Admella, C., Hidalgo, L.A., Clavé, P., Suñol, X.: Sentinel lymph node biopsy as a prognostic factor in non-metastatic colon cancer: a prospective study. Clin. Transl. Oncol. 19(4), 432–439 (2017)
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Micu, B.V. et al. (2019). Prognostic Implications of Sentinel Lymph Node Mapping in Stage I and II Colorectal Cancer Patients. In: Vlad, S., Roman, N. (eds) 6th International Conference on Advancements of Medicine and Health Care through Technology; 17–20 October 2018, Cluj-Napoca, Romania. IFMBE Proceedings, vol 71. Springer, Singapore. https://doi.org/10.1007/978-981-13-6207-1_47
Download citation
DOI: https://doi.org/10.1007/978-981-13-6207-1_47
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6206-4
Online ISBN: 978-981-13-6207-1
eBook Packages: EngineeringEngineering (R0)